Ciclopirox
Pricing Report NDC 0168-0522-04

Latest NADAC: $0.60404 per ML · Effective Feb 22, 2017 · Est. package price $72.48 (120 ML)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Ciclopirox (NDC 0168-0522-04) is $0.60404 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 22, 2017.

As a provided by Fougera Pharmaceuticals Inc., this medication is distributed in a 1 BOTTLE, PLASTIC in 1 CARTON / 120 mL in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.60404
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Feb 22, 2017
Billable Units
120 ML
Estimated Package Price
$72.48
Data Status
As of Mar 01, 2017
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0168-0522-04
Description
1 BOTTLE, PLASTIC in 1 CARTON / 120 mL in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.52171 to $0.80742 per ML. Over this 3 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5217 - $0.8074
Market Volatility
54.76% Variance
Latest Trend
0.64%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 22, 2017 $0.60404 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2017 $0.60018 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $0.66911 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2016 $0.57117 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2016 $0.62658 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2016 $0.71426 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2016 $0.55776 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2016 $0.73930 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 22, 2016 $0.69990 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 18, 2016 $0.71118 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 20, 2016 $0.75597 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 23, 2016 $0.76793 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026